BioSpace News Archive

Asensus Surgical, Inc. today announced that it has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance® System.

Sol-Gel Technologies, Ltd. today announced that it will present at H.C. Wainwright’s Autoimmune & Inflammatory Disease Virtual Event on Thursday, March 30, 2023.

Societal CDMO, Inc. announced that the United States Food and Drug Administration has approved the company as a manufacturer of a commercial tablet product.

ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Vitargus® Phase II Site Initiation Visit (SIV) at Srinagarind Hospital, Khon Kaen University (TH002) was successfully conducted on March 9-10, 2023.

DolCas Biotech, LLC and its concentrated turmeric extract, Curcugen®, have been selected by nutritional supplement company, Clear Within, for its vegan nutricosmetic.

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance Treg function, including biologics and cell therapies, today announced a worldwide agreement with Dr. Reddy’s Laboratories Limited.

Abcam plc today announces its results for the year ended 31 December 2022 (the ‘period’).

Cure Rare Disease (CRD) - a nonprofit biotechnology company focused on developing treatments for ultra-rare diseases - announces the appointment of leading experts in the fields of gene therapy and neuromuscular disorders to its Scientific Advisory Board (SAB).

Stereotaxis announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida.

InvisiShield Technologies Ltd. today announced a collaboration with Gladstone Institutes to develop intranasal preventatives against airborne infection, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV).